Alerts will be sent to your verified email
Verify EmailBRAWN
|
Brawn Biotech
|
Fraser and Co
|
Ramasigns Industries
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-11.92 % | 6.71 % | -6.35 % |
|
5yr average Equity Multiplier
|
2.13 | 2.28 | 1.43 |
|
5yr Average Asset Turnover Ratio
|
1.68 | 1.64 | 0.27 |
|
5yr Avg Net Profit Margin
|
-6.0 % | -770.96 % | -9.64 % |
|
Price to Book
|
1.78 | 1.12 | 0.68 |
|
P/E
|
0.0 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
67.06 Days | 0.0 | 592.16 Days |
|
Inventory Days
|
61.84 Days | 0.89 Days | 0.0 |
|
Days Receivable
|
101.77 Days | 0.0 | 0.0 |
|
Days Payable
|
118.16 Days | 86.41 Days | 189.07 Days |
|
5yr Average Interest Coverage Ratio
|
-18.52 | 23.07 | -1275.03 |
|
5yr Avg ROCE
|
-10.05 % | 9.81 % | -6.25 % |
|
5yr Avg Operating Profit Margin
|
-6.76 % | -473.72 % | -7.3 % |
|
5 yr average Debt to Equity
|
0.0 | 0.04 | 0.01 |
|
5yr CAGR Net Profit
|
n/a | n/a | 66.2 % |
|
5yr Average Return on Assets
|
-5.5 % | 2.87 % | 15.42 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
53.66 % | 3.12 % | 34.93 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 100.0 % |
|
Change in Promoter Holding (3 Yrs)
|
-0.07 % | 3.12 % | -18.78 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.24 % | 0.0 | 0.02 % |
|
Brawn Biotech
|
Fraser and Co
|
Ramasigns Industries
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|